144 related articles for article (PubMed ID: 33415019)
1. An exploratory analysis about cycles of adjuvant chemotherapy and outcomes by substage for stage I ovarian clear cell carcinoma: a single institution retrospective study.
Wang T; Zeng J; Li N; Zhang R; Song Y; Wu L
Am J Cancer Res; 2020; 10(12):4561-4567. PubMed ID: 33415019
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma.
Kawabata A; Yanaihara N; Nagata C; Saito M; Noguchi D; Takenaka M; Iida Y; Takano H; Yamada K; Iwamoto M; Kiyokawa T; Okamoto A
Gynecol Oncol; 2017 Sep; 146(3):609-614. PubMed ID: 28673661
[TBL] [Abstract][Full Text] [Related]
3. Ovarian clear cell carcinoma, outcomes by stage: the MSK experience.
Shu CA; Zhou Q; Jotwani AR; Iasonos A; Leitao MM; Konner JA; Aghajanian CA
Gynecol Oncol; 2015 Nov; 139(2):236-41. PubMed ID: 26404183
[TBL] [Abstract][Full Text] [Related]
4. Positive Ascites Cytology, Postoperative Chemotherapy and Prognosis of Stage I Ovarian Clear Cell Carcinoma.
Kubo-Kaneda M; Kondo E; Okugawa T; Yamawaki T; Hirata T; Tsuji M; Nagao K; Kato M; Yoshimura K; Ikeda T
Anticancer Res; 2023 Aug; 43(8):3799-3805. PubMed ID: 37500143
[TBL] [Abstract][Full Text] [Related]
5. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
[TBL] [Abstract][Full Text] [Related]
6. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis.
Yin M; Yang J; Zhou H; Liu Q; Li S; Zhang X
Front Oncol; 2022; 12():811638. PubMed ID: 35656506
[TBL] [Abstract][Full Text] [Related]
7. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.
Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB
Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967
[TBL] [Abstract][Full Text] [Related]
8. Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.
Sun M; Jiang W
Discov Oncol; 2023 Apr; 14(1):39. PubMed ID: 37004660
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological and survival analysis of 34 cases of uterine clear cell carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):345-350. PubMed ID: 33752316
[No Abstract] [Full Text] [Related]
10. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
[TBL] [Abstract][Full Text] [Related]
11. Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution.
Shi Y; Dai M; Zhang Y; Qi Y; Li Z; Cai H
Cancer Manag Res; 2021; 13():2215-2222. PubMed ID: 33692636
[TBL] [Abstract][Full Text] [Related]
12. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
[TBL] [Abstract][Full Text] [Related]
13. Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience.
Liu SL; Tinker AV
Gynecol Oncol Rep; 2020 Feb; 31():100533. PubMed ID: 31970284
[TBL] [Abstract][Full Text] [Related]
14. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
[TBL] [Abstract][Full Text] [Related]
15. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
[TBL] [Abstract][Full Text] [Related]
16. Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational study.
Imterat M; Bizzarri N; Fruscio R; Perrone AM; Traut A; du Bois A; Rosati A; Ferrari D; De Iaco P; Ataseven B; Ergasti R; Volontè S; Tesei M; Heitz F; Perri MT; Concin N; Fanfani F; Scambia G; Fagotti A; Harter P
Int J Gynecol Cancer; 2023 Jan; 33(1):42-49. PubMed ID: 36104079
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.
Mayadev J; Elshaikh MA; Christie A; Nagel C; Kennedy V; Khan N; Lea J; Ghanem A; Miller D; Xie XJ; Folkert M; Albuquerque K
Am J Clin Oncol; 2018 Dec; 41(12):1220-1224. PubMed ID: 29683799
[TBL] [Abstract][Full Text] [Related]
18. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
Manning-Geist B; Gordhandas S; Hodgson A; Zhou QC; Iasonos A; Chi DS; Ellenson L; Aghajanian CA; Abu-Rustum NR; Leitao M; Long K; Rubinstein MM; Sonoda Y; Alektiar K; Weigelt B; Zivanovic O; Grisham RN
Int J Gynecol Cancer; 2022 Dec; 32(12):1576-1582. PubMed ID: 36368707
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
[TBL] [Abstract][Full Text] [Related]
20. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
